Markus Keiser
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 24
- Drug Transport and Resistance Mechanisms 23
- Polyomavirus and related diseases 1
-
- Pharmacogenetics and Drug Metabolism 8
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Stefan Oswald (21 shared papers)Werner Siegmund (18 shared papers)Markus Grube (7 shared papers)Werner Weitschies (5 shared papers)Jens‐Peter Kühn (3 shared papers)Heyo K. Kroemer (5 shared papers)Janett Müller (3 shared papers)Hassan Y. Naim (6 shared papers)
- Journals
- Molecular Pharmaceutics (5 papers)Drug Metabolism and Disposition (4 papers)Clinical Pharmacology & Therapeutics (3 papers)Journal of Pharmaceutical Sciences (2 papers)Gastroenterology (2 papers)
- Partner nations
- GermanySwedenSwitzerland
In The Last Decade
Markus Keiser
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 75
- Oncology 639
- Pharmacology 189
- Pharmaceutical Science 91
- Hepatology 108
- Radiology, Nuclear Medicine and Imaging 193
Countries citing papers authored by Markus Keiser
This map shows the geographic impact of Markus Keiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Keiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Keiser more than expected).
Fields of papers citing papers by Markus Keiser
This network shows the impact of papers produced by Markus Keiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Keiser. The network helps show where Markus Keiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Keiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 206 | |
| 2 | 2012 | 124 | |
| 3 | 2010 | 120 | |
| 4 | 2016 | 91 | |
| 5 | 2012 | 64 | |
| 6 | 2008 | 58 | |
| 7 | 2017 | 56 | |
| 8 | 2021 | 54 | |
| 9 | 2012 | 50 | |
| 10 | 2005 | 48 | |
| 11 | 2013 | 44 | |
| 12 | 2011 | 42 | |
| 13 | 2015 | 40 | |
| 14 | 2017 | 38 | |
| 15 | 2012 | 36 | |
| 16 | 2013 | 29 | |
| 17 | 2014 | 29 | |
| 18 | 2014 | 28 | |
| 19 | 2016 | 27 | |
| 20 | 2018 | 26 |
About Markus Keiser
Markus Keiser is a scholar working on Oncology, Pharmacology, Genetics, Pharmacology and Pharmaceutical Science, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacogenetics and Drug Metabolism (8 papers), Digestive system and related health (5 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Drug Solubulity and Delivery Systems (1 paper), Lysosomal Storage Disorders Research (1 paper) and Polyomavirus and related diseases (1 paper). The work is most often cited by research in Oncology (639 citations), Pharmacology (189 citations), Pharmaceutical Science (91 citations), Hepatology (108 citations) and Radiology, Nuclear Medicine and Imaging (193 citations). Markus Keiser has collaborated with scholars based in Germany, Sweden and Switzerland. Frequent co-authors include Stefan Oswald, Werner Siegmund, Markus Grube, Werner Weitschies, Jens‐Peter Kühn, Heyo K. Kroemer, Janett Müller, Hassan Y. Naim, Hartmut Glaeser and Martin F. Fromm. Their work appears in journals such as Molecular Pharmaceutics, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical Sciences and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.